Keeping ahead in China means adapting to a shifting market, analysts say

China with flag overlay

Many medical device companies have their eye on China – and with good reason – but the country’s approach to healthcare is shifting, and companies that hope to capitalize on the China’s exponential growth must be prepared to change with it, according to analysts at PricewaterhouseCoopers.

China’s healthcare market is an irresistibly attractive one, given recent spikes in healthcare spending and more surges projected down the line, but "the rules to succeed in China’s new economy are changing, and companies that are able to adapt may be well positioned to realize the benefits of participating in this important market," PwC researchers said.

China’s healthcare market is booming, fueled in part by aggressive government spending on healthcare reforms to expand insurance coverage and healthcare access, as well as by an aging population with strong underlying economic growth. Patients in China are seeing more chronic disease, but they are also developing larger margins of disposable income and demanding higher-quality healthcare, PwC reported. Together, those elements represent a recipe for rapid growth and an alluring market for medical device makers.

Per-capital healthcare spending in China grew 23% between 2006 and 2009, according to there report. The market was valued at $357 billion in 2011 and is projected to his $1 trillion in 2020, and medical device makers have already spend several years and millions of dollars developing a foothold through R&D investments and acquisitions. How Chinese players determine the value of a relationship, however, may have shifted in recent years away from strongly financial motives to more strategic interests.

"Mature Chinese companies no longer want cash, but rather technologies, managerial expertise, and new markets," according to PwC. "In return, they offer resources, relationships, and knowledge to succeed in a lucrative domestic market characterized by bureaucratic complexity, diverse regulations, and varied consumer preferences."

In response, multinational companies are putting more money into sales, R&D and manufacturing in China. Sometimes that means steering away from acquisitions and opting instead for joint ventures, which can be tricky business.

Joint ventures allow the foreign companies to reap the benefits of local know-how in navigating China’s regulatory environment and establishing channels to central and local authorities, among other things, but Chinese partners may barter for control over budgets, management appointments and other aspects of the relationship, PwC analysts noted.

"Multinationals will need to weigh these concessions carefully with the value represented by access to a market expected to be the world’s largest by 2025," according to the report.

Many medical device makers have considerable stakes in China as part of their larger emerging market strategies, including medtech giant Boston Scientific(NYSE:BSX), which in the summer of 2011 committed $150 million to a 5-year plan to expand its Chinese operations.

Last month Boston Scientific Asia-Pacific president Supratim Bose told that China represents the greatest opportunity among emerging markets for medical devices, and the company is adding 100-150 employees in China each year for the next 3 years.

In January orthopedic giant Stryker (NYSE:SYK) called its acquisition of Trauson Holdings the "key component" of its emerging market strategy.

"To date, Stryker’s presence in China has been focused on the premium segment, which is dominated by multinational players. However, the value segment of the market is growing at a faster rate, with local manufacturers the key players," Katherine Owen, Stryker’s vice president of strategy, said in a conference call with investors. "We have prioritized China and the value segment of the market in particular as a critical market, given that the device segment is growing at roughly 20% annually, with the overall market expected to more than double in the next 5 years."

RSS From Medical Design & Outsourcing

  • Saelig presents new Amplicon Impact-R 1100F series computer
    Saelig Company announces the Amplicon Impact-R 1100F series, a fanless system powered by the Intel ATOM D2550 processor. Configured with a high performance 2.5 in. MLC Solid State Drive (SSD), the Impact-R 1100F series is a silent controller system. With options for multiple serial communication ports, the Impact-R 1100F can offer up seven DB9 connections […]
  • Gerresheimer to acquire Centor
    Gerresheimer AG, a partner to the global pharmacy and healthcare industry, will further extend its pharmaceutical packaging business with the acquisition of Centor. Gerresheimer has reached an agreement with Nemera Development S.A. to acquire 100% of the share capital of Centor US Holding. “Centor is the highly profitable market leader for plastic vials and closures in […]
  • Methods Machine Tools presents the new Nakamura-Tome NTRX-300
    Methods Machine Tools, a developer of precision machine tools and automation, has introduced the new Nakamura-Tome NTRX-300, a multitasking turning center featuring complete parts machining in one operation, with a built-in load and unload automation system and advanced operator recognition management software. The NTRX-300 features true opposing twin spindles: an 8 in. A2-6 25 HP or […]
  • MSC Apex Diamond Python and Smart Midsurface speeds modeling to validation
    MSC Software announced a new release of MSC Apex, the company’s award-winning next generation Computer Aided Engineering (CAE) platform. The MSC Apex Diamond Python release introduces: · The fourth release of MSC Apex Modeler is a CAE Specific direct modeling and meshing solution that streamlines CAD clean-up, simplification and meshing workflow. New in this release is […]
  • Quality Metrics: FDA’s plan for a key set of measurements to help ensure manufacturers are producing quality medications
    Editor’s Note: This article is written by Ashley Boam and Mary Malarkey from the “FDA Voice” blog. Boam is an FDA’s acting Director of the Office of Policy for Pharmaceutical Quality, the Office of Pharmaceutical Quality and the Center for Drug Evaluation and Research. Malarkey is an FDA’s Director if the Office of Compliance and Biologics Quality […]
  • MasterControl’s CEO talks EQMS software and new partnerships
    MasterControl offers a quality and compliance software that helps device companies speed time to market and improve their bottom lines. Under Jon’s leadership, the company has blossomed into a market leader and has a unique corporate culture that fosters growth, excellence and quality. In this podcast, MasterControl’s CEO, Jon Beckstrand, will discuss electronic quality management […]
  • BIT Group launches white label IVD solutions
    BIT Group has launched a product line of customizable IVD white label instruments. During recent years, BIT has invested capital and resources developing customizable, ready-to-use IVD systems to address a growing demand. “The IVD market is challenging for our clients,” said Marius Balger, CEO at BIT. “OEM’s must adhere to a growing number of evolving IVD […]
  • Toshiba expands line-up of ARM Cortex-M-based microcontrollers
    Toshiba announced that it has enhanced its current “TX Family” of ARM core-based microcontrollers and started to develop three series of microcontrollers, “TXZ0 series,” “TXZ3 series” and “TXZ4 series,” as part of the “TXZTM Family.” The TXZTM Family is a new collection of flash microcontrollers that support low-power consumption and high-speed operation for IoT and M2M […]
  • Parker Hannifin consolidates, layoffs ahead
    Parker Hannifin plans to consolidate a number of internal divisions, close 2 facilities and expand its Mexican operations, according to an internally distributed letter from Andy Ross, Parker’s engineered materials group president. The company has confirmed the letter was authentic, but has not disclosed how many employees will be affected by the new plans or […]
  • 3-phase current transducer from PEM delivers all-in-one convenience
    The new RCTrms 3-ph current transducer from Power Electronic Measurements (PEM) delivers a convenient, safe and accurate solution for measuring current in three phases. It features a thin, clip-around, flexible sensor coil and provides accurate true rms measurement with 4-20 mA or 0-5 V output, enabling simple installation with PLC’s, SCADA systems or automation equipment. […]
  • Safety alert: Recall on two IV solutions from Baxter
    Baxter International announced it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital and user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The matter was identified prior to […]

Leave a Reply